ANNOVIS BIO TO HOLD LIVE WEBCAST TO REVIEW ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE CLINICAL PROGRAMS

Posted on by

Webcast to be held on Thursday, April 20th at 4pm EDT. BERWYN, Pa., April 13, 2023 /PRNewswire/ — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company addressing neurodegenerative diseases, today announced that the Company will hold a live…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.